# Clustering Approach 5 : MRNASEQ_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.00214528702407268	Range of duration = 0.2 to 357.37, nDeath = 87, nCensor = 81
2	AGE	ANOVA	0.0622863270455281	Range of values = 18 to 87, Mean = 56.0706, StdDev = 16.233, nMissing = 1
3	PRIMARY.SITE.OF.DISEASE	Chi-square test	1.45874089638238e-05	nTypes = 4 (DISTANT METASTASIS/PRIMARY TUMOR/REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)/REGIONAL LYMPH NODE), nPatients = 25/1/33/112
4	GENDER	Fisher's exact test	0.623520616914133	nTypes = 2 (FEMALE/MALE), nPatients = 66/105
5	DISTANT.METASTASIS	Chi-square test	0.647155734710201	nTypes = 5 (M0/M1/M1A/M1B/M1C), nPatients = 148/2/2/2/2, nMissing = 15
6	LYMPH.NODE.METASTASIS	Chi-square test	0.464898852353565	nTypes = 10 (N0/N1/N1A/N1B/N2/N2A/N2B/N2C/N3/NX), nPatients = 95/2/6/16/1/4/10/5/16/2, nMissing = 14
7	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 171
8	NEOPLASM.DISEASESTAGE	Chi-square test	0.332597652097959	nTypes = 13 (I OR II NOS/STAGE I/STAGE IA/STAGE IB/STAGE II/STAGE IIA/STAGE IIB/STAGE IIC/STAGE III/STAGE IIIA/STAGE IIIB/STAGE IIIC/STAGE IV), nPatients = 4/17/10/14/19/8/10/8/9/5/17/23/6, nMissing = 21